5ARI

DRUG4 trials

Sponsors

GlaxoSmithKline, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions

BPHDepressionProstatic HyperplasiaSuicide

Unknown Phase

Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan

CompletedNCT01323998

GlaxoSmithKlineProstatic Hyperplasia

Start: 2010-04-30End: 2010-06-30Updated: 2017-07-06

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

CompletedNCT01376258

GlaxoSmithKlineProstatic Hyperplasia

Start: 2010-10-31End: 2010-12-31Updated: 2017-05-22

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

CompletedNCT01386983

GlaxoSmithKlineProstatic Hyperplasia

Start: 2009-03-31End: 2010-06-30Updated: 2017-05-17

5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

CompletedNCT02876757

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sBPH, Depression, Suicide

Start: 2003-01-31End: 2017-03-31Updated: 2024-01-12